Search results for "Coronavirus"
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://immattersacp.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
https://immattersacp.org/weekly/archives/2021/10/19/2.htm
19 Oct 2021
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2020
Resolve to get involved in advocacy in 2022
While ACP has achieved several advocacy wins over the past year, physicians and their practices face ongoing challenges, and physicians themselves are needed to fight for changes.
https://immattersacp.org/archives/2022/01/resolve-to-get-involved-in-advocacy-in-2022.htm
1 Jan 2022
Getting patients to ‘yes' on COVID-19 vaccines
Experts believe practicing physicians are well positioned to take a lead role combating one of the biggest anticipated obstacles to widespread vaccination: vaccine hesitancy.
https://immattersacp.org/archives/2021/01/getting-patients-to-yes-on-covid-19-vaccines.htm
1 Jan 2021
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum X: Current Clinical Challenges in COVID-19 Prevention and Management
During the Sept. 7 virtual live event, a panel of experts will discuss current methods for preventing and managing SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/08/30/4.htm
30 Aug 2022
Physician resources available for MERS
The first case of Middle East Respiratory Syndrome (MERS) has been reported in the United States. This issue has been followed closely by the Centers for Disease Control (CDC) and the Department of Health and Human Services (HHS) over the past several months, as its arrival in the U.S. and its 30% mortality rate have raised the level of attention and concern.
https://immattersacp.org/weekly/archives/2014/05/06/6.htm
6 May 2014
Continuous glucose monitoring gains traction in hospitals
Real-time continuous glucose monitoring is seeing a real-world trial after the FDA stated it would not object to its use during the COVID-19 pandemic
https://immattersacp.org/archives/2021/03/continuous-glucose-monitoring-gains-traction-in-hospitals.htm
1 Mar 2021
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/03/15/5.htm
15 Mar 2022